메뉴보기
    HOME

    RESEARCH

    • up
    • down
    • Microtracing/microdosing Study
    • Use of Artificial Intelligence for Clinical Drug Development
    • Policy Analysis for an Integrated Clinical Research System in Korea
    • Systems Pharmacology and Pharmacometrics
    • Writing an Introductory Book on Biologics

      Policy Analysis for an Integrated Clinical Research System in Korea

      CCADD is studying the strategic policy issues to efficiently and seamlessly integrate standalone clinical research systems in Korea such as drug- or disease-registries (public or private), open databases created by the government, and hospital’s electronic medical records (EMRs). This study is sponsored by the Korea National Enterprise for Clinical Trials (KoNECT).
      In this study, CCADD has first enumerated the available clinical trial resources in Korea followed by a systematic investigation of the current legal, societal, and cultural frameworks that have prevented clinical trial systems being fully integrated. CCADD has also studied the following topics:
      Current status of integration of EMR data in Korea
      Technologies available for integration of public health data and hospital EMRs
      Availability of a metadata model for integrated clinical research systems in other countries
      Roles and responsibilities of the centralized coordinating center for integrated clinical research systems
      The results of this study will be published as a white paper around the end of 2017.

    CCADD

    Center for Convergence Approaches in Drug Development, Graduate School of Convergence Science and Technology, Seoul National University

    Room C-208, 145 Gwanggyo-ro, Yeongtong-gu, Suwon-si, Gyeonggi-do, 16229, SOUTH KOREA (Gwanggyo)

    Room 406, Building 17, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, SOUTH KOREA (Yeon-gun)

    Tel: +82-31-888-9189 (Gwanggyo); +82-2-3668-7381 (Yeon-gun)

    Fax: +82-31-888-9575

    Email: ccadd.snu@gmail.com